Naying He1, Yu Liu1, Bin Xiao2, Junchen Li3, Chencheng Zhang4, Yijie Lai4, Feng Shi5, Dinggang Shen5, Yan Li1, Hongjiang Wei6, Ewart Mark Haacke1,7, Weibo Chen8, Qian Wang2, Dianyou Li4, and Fuhua Yan1
1Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 2Institute for Medical Imaging Technology, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China, Shanghai, China, 3Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, No. 6 Huanghe Road, Changshu, China, Changshu, China, 4Department of Neurosurgery, Center for Functional Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai, China, 5Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China, Shanghai, China, 6Institute for Medical Imaging Technology, Department of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China, Shanghai, China, 7Department of Radiology, Wayne State University, Detroit, Michigan, USA, Detroit, MI, United States, 8Philips Healthcare,Shanghai,China, Shanghai, China
Synopsis
Currently, there are neither individual
objective nor quantitative indicators for predicting DBS motor outcome. We
hypothesized that the distribution of SN iron changes in PD patients may
reflect a specific disease trait and could potentially account for some
variability in the motor outcomes after sub-thalamic nucleus (STN) deep brain
stimulation (DBS). We developed a
radiomics model with machine learning (RA-ML) based on preoperative individual
QSM of the SN to predict motor outcome for STN-DBS in PD and it performed best
with an AUC of 0.897. In addition, the threshold probability of the RA-ML model
can differentiate surgical responders and non-responders.
Introduction
Currently, there are neither individual objective nor
quantitative indicators for predicting DBS motor outcome preoperatively,
warranting the search for imaging biomarkers to predict surgical efficacy and
screen for suitable candidates. We hypothesized that the distribution of iron
changes in the SN in PD patients may reflect a specific disease trait and could
potentially account for some variability in the motor outcomes after
sub-thalamic nucleus (STN) deep brain stimulation (DBS) surgery. In this study,
we take advantage of radiomics analysis with machine learning to investigate
the correlation between the preoperative QSM data of the SN and post-operative
clinical motor outcome as assessed with the Unified Parkinson’s Disease Rating
Scale Part III (UPDRS-III) in PD patients. We combined MRI imaging radiomic
features, presurgical clinical information and postsurgical motor outcome to
establish a noninvasive, predictive model for PD patients who may require STN
DBS surgery.Methods
Twenty PD patients were
scanned consecutively at 3T (Ingenia, Philips Healthcare, Netherlands) with a three-dimensional
multi-echo gradient-recalled echo sequence (medication OFF) 1-3 days before the
STN DBS surgery. The third section of Unified Parkinson's disease Rating Scale
(UPDRS-III) scores were recorded 1-3 days before and 6 months after DBS surgery.
All patients were scanned with a 15-channel phased array head coil using a
multi-echo GRE sequence. Thin foam pads both under and beside the head were
used to stabilize the head and reduce possible motion artifacts. The imaging
parameters were chosen as follows: voxel size = 1× 1 × 1 mm3; flip
angle = 12o; repetition time (TR) = 25 ms; eight echoes with the first echo time (TE1) =
3.3 ms; echo spacing (ΔTE) = 2.6 ms; sampling bandwidth = 673 Hz/pixel; matrix
size = 220 × 220; number of slices = 136; phase encoding SENSE acceleration
factor = 2; and a total acquisition time of 6 minutes and 16 seconds. The long
axis of the sagittal imaging slab was placed perpendicular to the anterior
commissure-posterior commissure (AC-PC) line. Regions of interest (ROIs) of the
bilateral SN were drawn semi-automatically. Subsequently, volumes of interest
(VOIs) were segmented for extracting radiomic features with machine learning.
Finally, two logistic regression models (with or without clinical information: disease
duration, the preoperative levodopa equivalent daily dosage, and response to
the levodopa challenge test) based on recursive feature elimination was utilized
to classify responders and non-responders (30% as cut-off decrease percentage
of pre- and post-surgical UPDRS-III rating scores) in global motor outcome. The processing pipeline of the radiomics model with machine learning is
shown in Fig. 1.Results
Our radiomics-based analysis (RA-ML) model performs best with an accuracy of
81.2% (AUC=0.897) with respect to the global motor outcome after DBS surgery (Fig.
2.). The accuracy drops to 72.5% (AUC=0.836) after the inclusion of several
related clinical variables. In addition, significantly greater GLDM Dependence Variance
(GLDM-DV) (p=0.019) and GLRLM Long Run Low Gray Level Emphasis (p=0.041)
radiomic values in the SN for non-responders was seen compared to responders. Furthermore,
in this model, all test samples whose probability scores were greater
than 0.75 or less than 0.1 were correctly classified as responder (pink) or
non-responder (blue), respectively (Fig. 3.).Discussion and conclusion
To our knowledge, this is the first study to
investigate whether preoperative QSM features of iron in the SN derived by
radiomics with machine learning can predict motor improvement in PD patients
after STN DBS. The motor outcome of STN-DBS in PD patients is heterogeneous,
thus addressing risk–benefit profiles and imposing proper treatment are of
vital importance for individuals. The key result in this study relates to
creating a noninvasive model with an AUC as high as 0.897 and threshold
probability for clinical use in counselling candidates for DBS surgery.
Compared with traditional manual analysis, a radiomics-based analysis using
machine learning suggests that information as gleaned from preoperative QSM may
capture the subtle change of iron deposition in the SN, the most vulnerable
target in PD progression. Hence, this QSM based feature can be identified as a
potential imaging biomarker for predicting successful DBS outcome. In addition,
the semi-automated boundary detection approach we used in this study provides
high consistency and reliability between raters. Acknowledgements
No acknowledgement found.References
1.
A. Zaidel, H. Bergman, Y. Ritov, Z. Israel, Levodopa and
subthalamic deep brain stimulation responses are not congruent. Movement disorders : official journal of the
Movement Disorder Society 25,
2379-2386 (2010).
2.
A. E. Oakley, J. F. Collingwood, J. Dobson, G. Love, H. R. Perrott,
J. A. Edwardson, M. Elstner, C. M. Morris, Individual dopaminergic neurons show
raised iron levels in Parkinson disease. Neurology
68, 1820-1825 (2007).
3. N. He, J. Langley, D.
E. Huddleston, S. Chen, P. Huang, H. Ling, F. Yan, X. Hu, Increased
iron-deposition in lateral-ventral substantia nigra pars compacta: A promising
neuroimaging marker for Parkinson's disease. NeuroImage. Clinical 28,
102391 (2020).
4.
E. M. Haacke,
S. Liu, S. Buch, W. Zheng, D. Wu, Y. Ye, Quantitative susceptibility mapping:
current status and future directions. Magnetic resonance imaging 33, 1-25
(2015).
5.
C. Liu, W. Li,
K. A. Tong, K. W. Yeom, S. Kuzminski, Susceptibility-weighted imaging and
quantitative susceptibility mapping in the brain. Journal of magnetic resonance
imaging : JMRI 42, 23-41 (2015).